{"name":"Shanghai Bao Pharmaceuticals Co., Ltd.","slug":"shanghai-bao-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOV0U4T093azJDRWt1OU1Ya3VFaHRzN2Z6YWwxS3N2Q2ttdVU1OHNCVlpyZmtsOG1hT0pLdTNXWWhxSkc1VGpDLUN6Q2ZlUzNrZzlMMlUyRlFROXlIZHFFODBQVjVWNkRjRndkRTljZW0zZkp6UVZkOTl6VmFwcnU1S0NqSHhRSEdCUk4zeGdYclNyalJqNWtOTWswZEZ2YkpIZkp5cEJ0S096ajVDa2FOOE1YdmZ6S2g5bnZEVjVsODU1eXhqZ1lTZENvcw?oc=5","date":"2026-04-08","type":"pipeline","source":"TipRanks","summary":"Shanghai Bao Pharma Wins NMPA Nod for Recombinant Human Hyaluronidase Injection - TipRanks","headline":"Shanghai Bao Pharma Wins NMPA Nod for Recombinant Human Hyaluronidase Injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOaTBGU0tYMy04TWJGendvckYwUUVZZXJnOTA3YTF0SkNpMWdrOGRfSF9hOGFzNUNISkxrV1VRaldKT200OTF6aHlYYjB2RHlQUWpXUUdPOG0xbHVuaTZQWjhEa0tMZnhIT21hWDVaZlVoSlRSSVZzeFJBYzNOYTJ2ZjYxdU1RbGZDVkdzNzBIWEpzNTd4RkZqV2lrX01vaVVUeWZGaHpIRWtnM24xMS1HSDVmeklDcDJiSVd5NFFSQlVpYlZvOVZhUA?oc=5","date":"2026-03-31","type":"pipeline","source":"thestandard.com.hk","summary":"Shanghai Bao Pharmaceuticals’ Hong Kong IPO retail tranche 13.9 times covered - thestandard.com.hk","headline":"Shanghai Bao Pharmaceuticals’ Hong Kong IPO retail tranche 13.9 times covered","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNM1JOblozSldUVTdXbk54aHhndVpwc1lhV1d6Rl9TUEhqc0w0MmlkdWdiWW91MlM3X1piXy1iNVZHeko3RUZPNThsT215TkloSkFiMnpZWVR4VE51YzhSa1J0c3A3eHVxSzRaSGUxc1UySm0waVNvYnlLbDlKSm5FajZWZjFHbHhMR2JaVUlVV3RhU3g4al8wZldpaFctRjR2ZDNFa0hGcFBsS25UVzAydE1aMHJoYmJaX3hobmtYQ0JjaUFVTXZkMEY2UW1SeWFxMkRybUFlbmExcHF3c2JiRW5vNDdZVHlaSGVVUE84RUNISlc1Q3RN?oc=5","date":"2026-03-17","type":"regulatory","source":"The Globe and Mail","summary":"Shanghai Bao Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results - The Globe and Mail","headline":"Shanghai Bao Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQWHhabDZXemlwYzdkOXNKRk1FUC1KUUZ2VHd2VWIzSkxBaEhRbGJhTVE1V041cGl0RHRRSU5BT2FuelM2UkhsdUpTb1NkTHhNcUx2eGF2SXlNUlhob1NGN2lNeU1RcUNOR2w5SmVqM1hacG9tcUtabEFKTEE4dWpjdjMzZm9wSWFUbWdoaTVPS21LR280T0NHUWhaQ2ZnaTkzZkJNWV9JVVJpZm9pLWN3NHVWQmxQNXV6ZFVyUEhYaW9RZG9Sa0F3LWdteXpXaEFhQUV1MXB0dFRJS1RHcmc?oc=5","date":"2026-03-12","type":"trial","source":"The Globe and Mail","summary":"Shanghai Bao Pharma Wins NMPA Nod for New KJ101 Gastroscopy Trial - The Globe and Mail","headline":"Shanghai Bao Pharma Wins NMPA Nod for New KJ101 Gastroscopy Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPWWpXSlUtQ1ZzYXRfenZYeEQwTTFkanhSSGJkcE9vSm5sRkxWd0dGanBkLVVDNWFJVzQ1akw5TEdtcTA1bG1nOHB2QXBTdnpUTjJzY21rYUh0dUZaRUJGUDBmTnJQMmhoMVdQM1BvS21BUjRZSm5Pa3pSREo0MUc1VUdlRzNsRzJrbW1sVm80QWU1NVBiUzg2Qy1sN1dmVmVWQjVmNWREdVlzeGZEUDFPclBFTGpEalc0SHZPaWFGeGh1dTlaaktIUVcwSmZERWxUUmUzMFlScFFLamc?oc=5","date":"2026-03-09","type":"pipeline","source":"Minichart","summary":"Shanghai Bao Pharmaceuticals Included in Stock Connect Program to Expand Investor Access and Liquidity - Minichart","headline":"Shanghai Bao Pharmaceuticals Included in Stock Connect Program to Expand Investor Access and Liquidity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPMlIyc1c3RHAwRWxEMUZreTMxNUsxdmZHSTJJUFByNkhvYUprY1Y4Vk9DdkJxRHk2YVllbG1RWHQ2MTVjSWgxOGNad2xBRGx5U2ZJSzdtM3FsTmNIeXhETndGQnlnUnQ0dGNXYm5ST0swZ25DRk1Qc2ZWdFotRjN3TVlOaTg?oc=5","date":"2025-12-10","type":"pipeline","source":"thebambooworks.com","summary":"BRIEF: Bao Pharma doubles in Hong Kong trading debut - thebambooworks.com","headline":"BRIEF: Bao Pharma doubles in Hong Kong trading debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBiV2J6NmZUZ1hMeFkwT3JDNXFfOTFlelFnX3RMNEhUTnpEZjVxbmdXdE9MeVNKNmplanBTZGloZ0JMQW12b0NtLW0wdTdRSzlqQm9pV281bEYxQXFkMXNwcVdYaVFBSFZETTlVU2FCWjZfU0xkNmJHYTVyLVZaUQ?oc=5","date":"2025-12-02","type":"pipeline","source":"thebambooworks.com","summary":"BRIEF: Bao Pharma launches $128 million Hong Kong IPO - thebambooworks.com","headline":"BRIEF: Bao Pharma launches $128 million Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQZnU0R0lYQ2JOdHIyQ1UwN1VBSTJIRTJkeGQ2dkxCekt6T2t0TjBNaWpyTU9PQ21lbk5YMmFzckNzMG9fb3R2QU42MW9IdWhXN3N3SzdrTzNNMGhlT0REV2hYYzM0RDB2QkNtLVplbEV0VWNiUkFSclVYMF9PazBlbGE1TG10SXpUaWFtdFdTNDloMlE3NlpjdC10TWVtbk1xVWhmTFNURDFHRkhRTEE?oc=5","date":"2025-08-04","type":"deal","source":"BioXconomy","summary":"Eyes on Asia: Shinyaku’s $735m DMD deal, Kite turns back in China, and more - BioXconomy","headline":"Eyes on Asia: Shinyaku’s $735m DMD deal, Kite turns back in China, and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5fcFpFaG8yRi1IRTd2ZnpTUTRQUmozdnJZS2FFOVRYVDRKQ25WTWNNYUVDUzNYSnFMdjhVQllEdm1GdnNqUnZLUDY0NHNjX2ZIUHF3?oc=5","date":"2025-04-07","type":"pipeline","source":"FirstWord Pharma","summary":"DualityBio seeks to raise up to $200M in Hong Kong listing amid market upheaval - FirstWord Pharma","headline":"DualityBio seeks to raise up to $200M in Hong Kong listing amid market upheaval","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfXzlpSHVWZHFkWllHeFdxSDBJYWhOZWtTLWcxeVJTS3M1Q2o4bmwyLXlwY0JZX2NFX210OHhLbjVPNFBTNTRLNWdsbVBRSDV4RXM0aGNSZ1E0eGtsTzNF?oc=5","date":"2025-01-18","type":"trial","source":"nature.com","summary":"Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials - nature.com","headline":"Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE43S3BCV3ZiemxWN0d3ajh3V05pWjZUN2pOcVNLX1R3TzExU2YzdU1ybmN6SkM5NkdzaGFmSms4cDNSa2FXejBmeS1zdFBsUmtXemxtbk04akQwN19VbG00dV8wdDdlZXpMR2Y0?oc=5","date":"2024-09-16","type":"deal","source":"Femtech Insider","summary":"Organon Partners with BaoPharma to Bring Innovative Long-Acting FSH Treatment to China - Femtech Insider","headline":"Organon Partners with BaoPharma to Bring Innovative Long-Acting FSH Treatment to China","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}